DOD-CDMRP: Prostate Cancer Research Program (PCRP) Clinical Consortium Award- Letter of Intent

Supports the development of a consortium that will facilitate the rapid execution of collaborative Phase II or Phase I/II clinical trials. Trials that incorporate investigations of biomarkers for risk assessment, early detection, prediction of aggressiveness, and/or progression of prostate cancer are encouraged. The consortium will consist of 10 Clinical Research Sites and one Coordinating Center.
Funding: Coordinating Center- $3.6M, Clinical Research Sites- $600K over 3 years.
https://cdmrp.org/Program_Announcements_and_Forms/